“A REVIEW OF OZEMPIC’S OFF LABEL USE FOR WEIGHT LOSS IN NON-DIABETIC INDIVIDUALS: CLINICAL EVIDENCE, SAFETY AND ETHICS”. 2026. Bioscience Insights 3 (3): 48-53. https://www.biosciinsights.com/index.php/BI/article/view/188.